Results 21 to 30 of about 5,590,035 (204)

Allogeneic hematopoietic stem cell transplantation in Tunisia [PDF]

Bone Marrow Transplantation, 2008
In 1998, the Tunisian team of the 'Centre National de Greffe de Moelle Osseuse' initiated allogeneic hematopoietic SCT (AHSCT) in Tunisia. As of June 2007, information was collected about 299 patients with a first AHSCT and 12 additional retransplants. The median age was 19 years (range 2-49 years). The main indications were aplastic anemia (n=106, 36%)
T, Ben Othman, L, Torjemane, A, Abdelkefi, A, Lakhal, S, Ladeb, L, Ben Hamed, H, Slama, A, Ben Abdeladhim   +7 more
openaire   +2 more sources

Renal dysfunction in allogeneic hematopoietic cell transplantation [PDF]

Kidney International, 2002
Allogeneic hematopoietic cell transplantation (HCT), formerly called bone marrow transplantation, can potentially cure various malignant and non-malignant diseases, but it is associated with a high risk of toxicity. We have previously shown an overall 21% incidence of severe acute renal failure in patients undergoing autologous HCT.
Parikh, Chirag R., McSweeney, Peter A., Korular, Didem, Ecder, Tevfik, Merouani, Aicha, Taylor, Jeremy, Slat-Vasquez, Vicki, Shpall, Elizabeth J., Jones, Roy B., Bearman, Scott I., Schrier, Robert W.   +10 more
openaire   +2 more sources

Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study [PDF]

, 2013
Fifty-five years after publication of the first hematopoietic stem cell transplantation this technique has become an accepted treatment option for defined hematologic and non-hematologic disorders.
Madrigal, Alejandro, Horowitz, Mary, Passweg, Jakob, Bouzas, Luis Fernando, Szer, Jeff, Niederwieser, Dietger, Gratwohl, Alois, Aljurf, Mahmoud, Iida, Minako, Kodera, Yoshihisa, Pasquini, Marcelo C., Marrow Transplantation,, Lipton, Jeff, Worldwide Network of Blood,, Gratwohl, Michael, Baldomero, Helen, Frauendorfer, Karl, Baldomero H, Niederwieser D, Horowitz M, Lipton J, Szer J, Kodera Y, Gratwohl M, Gratwohl A, Aljurf M, Iida M, Passweg J, Pasquini MC, Madrigal A, Bouzas LF, Frauendorfer K   +31 more
core   +1 more source

Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting [PDF]

Biology of Blood and Marrow Transplantation, 2019
Conditioning with fludarabine and low-dose total-body irradiation before allogeneic hematopoietic cell transplantation (HCT) enabled treating older or medically infirm patients with advanced hematologic malignancies in the outpatient setting. Between December 1997 and June 2017, 1037 patients with hematologic malignancies received peripheral blood stem
Noa Granot, Barry E. Storer, Jason P. Cooper, Mary E. Flowers, Brenda M. Sandmaier, Rainer Storb   +5 more
openaire   +5 more sources

Hematopoietic chimerism after allogeneic stem cell transplantation : a comparison of quantitative analysis by automated DNA sizing and fluorescent in situ hybridization [PDF]

, 2005
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is performed mainly in patients with high-risk or advanced hematologic malignancies and congenital or acquired aplastic anemias.
Wachowiak, Jacek, Tomasz Strabel, Peter Bader, Bader, Peter, Jólkowska, Justyna, Jacek Wachowiak, Michał Witt, Anna Pieczonka, Strabel, Tomasz, Pieczonka, Anna, Dariusz Boruczkowski, Boruczkowski, Dariusz, Justyna Jółkowska, Witt, Michal   +13 more
core   +2 more sources

Allogeneic Hematopoietic Cell Transplantation in Septuagenarians [PDF]

Biology of Blood and Marrow Transplantation, 2013
Acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) are diseases that affect predominantly older adults, and it is precisely this group of patients that continues to suffer from particularly poor outcomes [1-4]. Although hematopoietic cell transplantation (HCT) has emerged as an important treatment strategy for patients with high-risk ...
openaire   +2 more sources

Immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients [PDF]

, 2013
Despite the availability of new antifungal compounds, invasive fungal infection remains a significant cause of morbidity and mortality in children and adults undergoing allogeneic hematopoietic stem cell transplantation (HSCT). Allogeneic HSCT recipients
Lehrnbecher, Thomas, Thomas eLehrnbecher, Schmidt, Stanislaw, Thomas eKlingebiel, Tramsen, Lars, Lars eTramsen, Klingebiel, Thomas, Stanislaw eSchmidt, Stanislaw Schmidt, Lars Tramsen, Thomas Klingebiel, Thomas Lehrnbecher   +11 more
core   +1 more source

Allogeneic hematopoietic cell transplantation to treat two synchronous hematologic malignancies

, 2022
Allogeneic hematopoietic cell transplantation often represents the only solution for several poor-prognosis hematologic malignancies. The curative strategy for patients with synchronous hematologic disorders is always difficult and, in most cases ...
Enrico Santinelli*, Elisa Lindfors Rossi, Camilla Page, Raffaella Cerretti, Giulia Ciangola, Gottardo De Angelis, William Arcese, Benedetta Mariotti, Gianmario Pasqualone, Page Camilla, Arcese William, Mariotti Benedetta, Santinelli Enrico, De Angelis Gottardo, Rossi Elisa Lindfors, Pasqualone Gianmario, Cerretti Raffaella, Ciangola Giulia   +17 more
core   +1 more source

Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation [PDF]

, 2012
Background: Reconstitution of cytomegalovirus-specific CD3+CD8+ T cells (CMV-CTLs) after allogeneic hematopoietic stem cell transplantation (HSCT) is necessary to bring cytomegalovirus (CMV) reactivation under control. However, the parameters determining
Matthias Eder (21135), Borchers, Sylvia, Benno Wölk, Sylvia Borchers, Arnold Ganser, Pabst, Brigitte, Mischak-Weissinger, Eva Maria, Michael Stadler, Elke Dammann, Andrea Jarisch, Lehrnbecher, Thomas, Arnold Ganser (4454), Eva M. Weissinger (111202), Meral Yildiz, Schneider, Gisbert, Matthias Eder, Peter Bader, Melanie Bremm (111153), Koehl, Ulrike, Thomas Klingebiel, Michael Stadler (111171), Ulrike Koehl, Hans Martin, Benno Wölk (111163), Stadler, Michael, Thomas Lehrnbecher, Sylvia Borchers (111150), Wölk, Benno, Hans Martin (111179), Meral Yildiz (111168), Dammann, Elke, Thomas Klingebiel (111191), Brigitte Pabst (111160), Bader, Peter, Eder, Matthias, Jarisch, Andrea, Brigitte Pabst, Gisbert Schneider, Elke Dammann (111158), Gisbert Schneider (17096), Ulrike Koehl (111209), Thomas Lehrnbecher (111156), Klingebiel, Thomas, Esser, Ruth, Eva M. Weissinger, Ruth Esser (111165), Ganser, Arnold, Yildiz, Meral, Melanie Bremm, Peter Bader (111174), Eva M Weissinger, Bremm, Melanie, Andrea Jarisch (111185), Ruth Esser, Weissinger, Eva M., Köhl, Ulrike, Martin, Hans, Bader Peter, Klingebiel Thomas, Weissinger Eva M., Bremm Melanie, Koehl Ulrike, Pabst Brigitte, Martin Hans, Dammann Elke, Eder Matthias, Yildiz Meral, Jarisch Andrea, Stadler Michael, Wölk Benno, Esser Ruth, Ganser Arnold, Lehrnbecher Thomas, Borchers Sylvia, Schneider Gisbert   +74 more
core   +2 more sources

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma [PDF]

, 2004
We report the outcomes after reduced-intensity conditioning allogeneic stem cell transplantation (RIT) for non-Hodgkin lymphoma (NHL) in 88 patients (low-grade NHL [LG-NHL], n = 41; high-grade NHL [HG-NHL], n = 37; mantle cell lymphoma [MCL], n = 10 ...
Mahendra, P, Smith, GM, Cook, G., Hatton, C., Tighe, J., Morris, E., Goldstone, A, Peggs, K., Cook, G, Mahendra, Premini, Hunter, A., Mackinnon, S, Milligan, D., Smith, G.M., Goldstone, A., Chopra, R, Hunter, A, Linch, D., Parker, A, Linch, D, Morris, E, Hunter, A.H., Milligan, D, Thomson, K, Parker, A., Peggs, K, Chopra, R., Thomson, K., Craddock, C., Hatton, C, Mackinnon, S., Milligan, Donald, Mahendra, P., Schey, S., Craddock, Charles; id_orcid, Craddock, C, Schey, S, Tighe, J   +37 more
core   +1 more source